WO1998005794A1 - Device for forming an image of a transparent container - Google Patents

Device for forming an image of a transparent container Download PDF

Info

Publication number
WO1998005794A1
WO1998005794A1 PCT/BE1996/000080 BE9600080W WO9805794A1 WO 1998005794 A1 WO1998005794 A1 WO 1998005794A1 BE 9600080 W BE9600080 W BE 9600080W WO 9805794 A1 WO9805794 A1 WO 9805794A1
Authority
WO
WIPO (PCT)
Prior art keywords
image
container
forming means
image forming
light beam
Prior art date
Application number
PCT/BE1996/000080
Other languages
French (fr)
Inventor
Jean-Pierre Muylle
Original Assignee
Muylle Jean Pierre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Muylle Jean Pierre filed Critical Muylle Jean Pierre
Priority to AU66516/96A priority Critical patent/AU6651696A/en
Priority to EP96926274A priority patent/EP0925371A1/en
Priority to PCT/BE1996/000080 priority patent/WO1998005794A1/en
Publication of WO1998005794A1 publication Critical patent/WO1998005794A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Definitions

  • the present invention relates to a device for forming an image of a content of a transparent container, in particular a Petri dish, which container is provided for carrying at least one pharmaceutical tablet in a contaminated medium, said device comprising a carrier for carrying said container, a first light source provided for emitting a first light beam towards said container and image forming means for forming a first image of said content.
  • Such a device is known and for example commercialised by Sanofi Diagnostics Pasteur.
  • a high resolution camera is used as image forming means for forming said first image of the content of the container, and the first light source is provided at the same side of the carrier, in particular adjacent to said camera.
  • the image is formed on the basis of the first light beam which is at least partially reflected by the container.
  • an image is formed of the content of the container.
  • This image is further digitised by a computer, connected to said image forming means, and from such a digitised image, an inhibition zone, formed by the reaction of each of the pharmaceutical tablets with the contaminated medium and being essentially circular-shaped, is determined and further processed by the computer.
  • a problem with the known devices is that the formed image does not always clearly represent the inhibition zone(s), in particular the contour of the inhibition zone(s), so that the area of each inhibition zone can not be very accurately determined.
  • the invention has therefore as object to provide an apparatus which enables to form an image on which the contour of the inhibition zone(s) is more accurately formed.
  • the apparatus according to the invention is characterised in that said first light source and said image forming means are situated at opposite sides of said carrier, and that said carrier is provided for letting said first light beam through it in order to reach at least partially said image forming means.
  • inhibition zone(s) is (are) relatively more transparent than the contaminated medium, which in turn is more transparent than the pharmaceutical tablet(s), light will pass more easily through inhibition zone(s) than through the contaminated medium, and in its turn more easily than through the pharmaceutical tablet(s). Consequently, such an image made by transparency technique represents more accurately the contour of the inhibition zone(s). In this way, the area of each inhibition zone can better be determined and further processed.
  • the device according to the invention comprises a second light source, situated at the same side of said carrier than said image forming means, said second light source being provided for emitting a second light beam towards said container and said image forming means being further provided for forming a second image of said content on the basis of said second light beam at least partially reflected by said content.
  • the device comprises means for determining pixels in said first, respectively said second image, appertaining to said pharmaceutical tablet(s) and substitution means for substituting said pixels in said first image appertaining to said pharmaceutical tablet by said pixels in said second image appertaining to said pharmaceutical tablet.
  • substitution means for substituting said pixels in said first image appertaining to said pharmaceutical tablet by said pixels in said second image appertaining to said pharmaceutical tablet.
  • Figure 1 is a plan view of the content of a Petri dish with seven pharmaceutical tablets in a contaminated medium, which illustrates a first image formed by a first light beam passing at least partially through the Petri dish towards image forming means;
  • Figure 2 is a vertical side sectional view of an embodiment of the device according to the invention.
  • Figure 3 is a sectional view according to line Ill-Ill of Figure 2.
  • Figure 4 is a sectional view according to line IV-IV of
  • Figure 5 is a sectional view according to line V-V of Figure 4, illustrating the illumination of the second light source where a pharmaceutical tablet is situated;
  • Figure 6 is a sectional view according to line VI-VI of
  • Figure 7 is a sectional view according to line VII-VII of Figure 4, illustrating the illumination of the second light source where a inhibition zone is situated; and
  • Figure 8 is a plan view of the content of the Petri dish according to Figure 1 , which illustrates a second image formed by a second light beam at least partially reflected by the Petri dish and directed towards image forming means.
  • the device according to the invention is provided for forming an image of a content of a transparent container 1 , for example a Petri dish.
  • the container 1 comprises a contaminated medium 2, for example a medium comprising staphylococcus, and several pharmaceutical tablets 11-18, in particular antibiotic tablets such as Ampicillin. Each tablet is distinguishable for example by its colour or a mark applied on the upper surface of the tablet, for example (an) identification letter(s) ( Figure 8).
  • the device comprises a carrier 23 for carrying the container 1.
  • said carrier is formed by a front plate 25 and a slidable tray provided with a glass plate 24, onto which the container 1 can be placed.
  • said carrier is formed by a front plate and a tray provided with a plate having an opening onto which plate the container can be placed, whereby the area of the opening is slightly smaller than the area of the container 1 to be placed. In this way, the container 1 to be placed fits exactly on the carrier, whereby the opening is provided for letting a light beam passing through it.
  • said carrier comprises a fixed tray provided with a glass plate. The embodiments with the glass plate have the advantage, comparing to the embodiment with the plate having an opening, that the carrier is provided for carrying containers with a relatively wider range of dimensions.
  • the device further comprises a first light source 20 provided for emitting a first light beam (i.e. i 1T , iic and in), see Figure 4, towards said container 1 and image forming means 21 for forming a first image of the content of the container 1.
  • the image forming means 21 are for example formed by at least one sensor or a CCD camera. According to the invention, the first light source 20 and the image forming means 21 are situated at opposite sides of the carrier 23.
  • the device further comprises data processing means such as a PC, provided for being connected to the image forming means and programmed for processing the data of the formed image.
  • the device comprises a second light source 22, situated at the same side of the carrier 23 than the image forming means 21 , in particular adjacent to said image forming means.
  • the second light source 22 is provided for emitting a second light beam i 2 (i.e. i 2T , i 2 c and i 2 ⁇ ), see Figures 5-7, towards the container 1.
  • the image forming means 21 are further provided for forming a second image of the content of the container 1 on the basis of the second light beam i 2 at least partially reflected by said content.
  • the second light source preferably emits a light beam which does not deform colours so that the formed second image clearly represents the colours of the content of the container.
  • the device is enclosed in a closed box 26, so that the influence of external or ambient light is minimised.
  • a closed box 26 Preferably, the device is enclosed in a closed box 26, so that the influence of external or ambient light is minimised.
  • the first light source 20 emits, in a first step, a first light beam h towards the container 1.
  • a first light beam h As represented in Figure 4, three different sectors can be distinguished : sector T is a sector where a pharmaceutical tablet (indicated by 11-18 in Figures 1 and 8) is situated, sector C is a sector where the contaminated medium (indicated by 2 in Figure 1 ) is situated and sector I is a sector where an inhibition zone (indicated by 3-10 in Figure 1 ) is situated.
  • a first light beam i 1T emitted in a sector T will be reflected r ⁇ by the pharmaceutical tablet 13, since the pharmaceutical tablet is not transparent. In this sector, dark pixels will be formed on the image forming means.
  • a first light beam i c emitted in sector C will essentially pass through the contaminated medium and be transmitted tic to the image forming means, since the contaminated medium is essentially transparent.
  • a first light beam in emitted in sector I will essentially pass through an inhibition zone and be transmitted tn to the image forming means, since the inhibition zone is essentially transparent.
  • the image will consequently be clearly represented. Since an inhibition zone is more transparent than the contaminated medium, a small amount of the light beam i ⁇ c in sector C will be reflected r 1C) whereas a negligible amount of the light beam i 1t in sector I will be reflected.
  • the amount of light transmitted towards the image forming means 21 is represented by the longer dots of dotted line tn compared to the dots of dotted line t ⁇ C .
  • the carrier slides from a first position, wherein a first extremity 27 of the container 1 is illuminated, towards a second position, wherein a second extremity 28 opposite to said first extremity of the container 1 is illuminated (Fig. 3).
  • the results of the formed first image is illustrated in Figure 1. Since the main portion of the first light beam passes through the areas of the contaminated medium and the inhibition zone(s), these areas are clearly represented. Since the inhibition zone(s) is (are) more transparent than the contaminated medium, the contour of the inhibition zone(s) can clearly be distinguished.
  • the container could be provided with an identification label, such as for example a bar-code 19, in such a manner that when forming said first image, the identification label is also represented, so that formed images of different containers can easily be distinguished from each other.
  • the second light source 22 emits, in a second step, a second light beam i 2 towards the container 1.
  • a second light beam i 2T emitted in a sector T ( Figure 5) will be essentially reflected r 2 ⁇ by the pharmaceutical tablet 17 towards the image forming means 21 , since the pharmaceutical tablet is not transparent. Consequently a clear image of the pharmaceutical tablet will be formed on the image forming means.
  • a second light beam i 2C emitted in sector C ( Figure 6) will essentially pass through the contaminated medium and be transmitted t 2C , since the contaminated medium is essentially transparent.
  • a second light beam i 2 emitted in sector I ( Figure 7) will essentially pass through an inhibition zone and be transmitted t 2 ⁇ , since the inhibition zone is essentially transparent.
  • dark pixels will consequently be formed on the image forming means.
  • an inhibition zone is more transparent than the contaminated medium, a small amount of the light beam i 2c in sector C will be reflected r 2C , whereas a negligible amount of the light beam i 2 ⁇ in sector I will be reflected. Consequently the formed image of the inhibition zone will be darker than the formed image of the contaminated medium.
  • the carrier slides, such as in the first step, from a first position, wherein a first extremity 27 (Fig. 3) of the container 1 is illuminated, towards a second position, wherein a second extremity 28 (Fig. 3) opposite to said first extremity of the container 1 is illuminated.
  • the results of the formed second image is illustrated in Figure 8. Since the main portion of the second light beam reaching the pharmaceutical tablet(s) is reflected by these tablets, these tablets are clearly represented, whereas both the inhibition zones and the contaminated medium are less clearly represented compared to Figure 1.
  • the pharmaceutical tablets can be distinguished from each other by their different marks such as for example identification letter(s) : APN (Ampicillin), AMX (Amoxycillin), TMN (Temocillin), CPS (Cephalospo ⁇ ns of the first generation), CRX (Cefuroxime), CTX (Cefotaxime), CAZ (Ceftazidime) and TM (Tobramycim).
  • identification letter(s) APN (Ampicillin), AMX (Amoxycillin), TMN (Temocillin), CPS (Cephalospo ⁇ ns of the first generation), CRX (Cefuroxime), CTX (Cefotaxime), CAZ (Ceftazid
  • the carrier is slidably mounted in said device and the light sources 20, 22 and the image forming means 21 are fixed on said device.
  • said carrier is fixed and said light source(s) and said image forming means are slidably mounted in said device. If use is made of a CCD camera or (a) large sensor(s), neither the light source(s) and the camera, nor the carrier must be slidably mounted.
  • the advantage of the slidable arrangement is that the distance between the first light source and the image forming means, on the one hand, and between the container and the image forming means, on the other hand, can be relatively small, so that the device according to the invention can be made relatively compact.
  • the device according to the invention is dimensioned in such a manner that it fits in a standard tower of a PC, so that it can be integrated in a PC.
  • the device comprises data processing means, for example in the PC, for determining, in a further step, the location of the pixels in the first image appertaining to the pharmaceutical tablet(s). These pixels can easily be detected since they are darker than the pixels pertaining to the contaminated medium and the inhibition zone(s). Corresponding pixels, having the same location, are determined in the second image and retrieved therefrom. Substitution means are provided for substituting said pixels appertaining to said pharmaceutical(s) tablet in said first image by said retrieved corresponding pixels in said second image. In this way a third image is formed whereby both the inhibition zone(s) and the pharmaceutical tablet(s) are accurately formed.
  • the device according to the invention enables to determine accurately the areas of the inhibition zone(s) and to provide in this way a more accurate analysis of the effect of the pharmaceutical tablet(s) in a contaminated medium.
  • the second light source is not absolutely necessary. Indeed, from the formed first image, the contour of the inhibition zone(s) can be determined.
  • the pharmaceutical tablet(s) can not be distinguished from one another by their different colour of identification letter(s), but can be distinguished by their relative position to one another.
  • a marking is preferably provided on the container, so that each pharmaceutical tablet can be distinguished from another one by its relative position with respect to the marking.
  • An essential feature of the invention is consequently that use is made of the described arrangement of the first light source and image forming means, known as transparency technique, for forming an image of a content of a container comprising at least one pharmaceutical tablet in a contaminated medium.

Abstract

The present invention relates to a device for forming an image of a content of a transparent container, in particular a Petri dish, which container is provided for carrying at least one pharmaceutical tablet in a contaminated medium, said device comprising a carrier for carrying said container, a first light source provided for emitting a first light beam towards said container and image forming means for forming a first image of said content, whereby said first light source and said image forming means are situated at opposite sides of said carrier, and that said carrier is provided for letting said first light beam through it in order to reach at least partially said image forming means.

Description

"Device for forming an image of a transparent container"
The present invention relates to a device for forming an image of a content of a transparent container, in particular a Petri dish, which container is provided for carrying at least one pharmaceutical tablet in a contaminated medium, said device comprising a carrier for carrying said container, a first light source provided for emitting a first light beam towards said container and image forming means for forming a first image of said content.
Such a device is known and for example commercialised by Sanofi Diagnostics Pasteur. According to this known device, a high resolution camera is used as image forming means for forming said first image of the content of the container, and the first light source is provided at the same side of the carrier, in particular adjacent to said camera. The image is formed on the basis of the first light beam which is at least partially reflected by the container.
In this way, an image is formed of the content of the container. This image is further digitised by a computer, connected to said image forming means, and from such a digitised image, an inhibition zone, formed by the reaction of each of the pharmaceutical tablets with the contaminated medium and being essentially circular-shaped, is determined and further processed by the computer.
A problem with the known devices is that the formed image does not always clearly represent the inhibition zone(s), in particular the contour of the inhibition zone(s), so that the area of each inhibition zone can not be very accurately determined. The invention has therefore as object to provide an apparatus which enables to form an image on which the contour of the inhibition zone(s) is more accurately formed.
To this object, the apparatus according to the invention is characterised in that said first light source and said image forming means are situated at opposite sides of said carrier, and that said carrier is provided for letting said first light beam through it in order to reach at least partially said image forming means.
This enables to form an image by having said first light beam passing through the transparent container and reaching said image forming means. Since the inhibition zone(s) is (are) relatively more transparent than the contaminated medium, which in turn is more transparent than the pharmaceutical tablet(s), light will pass more easily through inhibition zone(s) than through the contaminated medium, and in its turn more easily than through the pharmaceutical tablet(s). Consequently, such an image made by transparency technique represents more accurately the contour of the inhibition zone(s). In this way, the area of each inhibition zone can better be determined and further processed. According to a first preferred embodiment, the device according to the invention comprises a second light source, situated at the same side of said carrier than said image forming means, said second light source being provided for emitting a second light beam towards said container and said image forming means being further provided for forming a second image of said content on the basis of said second light beam at least partially reflected by said content. This enables to form a more accurate image of the non transparent parts of the container to be illuminated, such as for example the pharmaceutical tablet(s), since those parts reflect the main portion of the light beam reaching it. According to a second preferred embodiment, the device according to the invention comprises means for determining pixels in said first, respectively said second image, appertaining to said pharmaceutical tablet(s) and substitution means for substituting said pixels in said first image appertaining to said pharmaceutical tablet by said pixels in said second image appertaining to said pharmaceutical tablet. In this way one image can be formed having both a clear contour of the inhibition zone(s) and an identification of the pharmaceutical tablet(s) accurately represented. The invention will now be described in detail, referring to the annexed drawings, wherein :
Figure 1 is a plan view of the content of a Petri dish with seven pharmaceutical tablets in a contaminated medium, which illustrates a first image formed by a first light beam passing at least partially through the Petri dish towards image forming means;
Figure 2 is a vertical side sectional view of an embodiment of the device according to the invention.
Figure 3 is a sectional view according to line Ill-Ill of Figure 2. Figure 4 is a sectional view according to line IV-IV of
Figure 2, illustrating the illumination of the first light source;
Figure 5 is a sectional view according to line V-V of Figure 4, illustrating the illumination of the second light source where a pharmaceutical tablet is situated; Figure 6 is a sectional view according to line VI-VI of
Figure 4, illustrating the illumination of the second light source where the contaminated medium is situated;
Figure 7 is a sectional view according to line VII-VII of Figure 4, illustrating the illumination of the second light source where a inhibition zone is situated; and Figure 8 is a plan view of the content of the Petri dish according to Figure 1 , which illustrates a second image formed by a second light beam at least partially reflected by the Petri dish and directed towards image forming means. The device according to the invention is provided for forming an image of a content of a transparent container 1 , for example a Petri dish. Referring to Figure 1 , the container 1 comprises a contaminated medium 2, for example a medium comprising staphylococcus, and several pharmaceutical tablets 11-18, in particular antibiotic tablets such as Ampicillin. Each tablet is distinguishable for example by its colour or a mark applied on the upper surface of the tablet, for example (an) identification letter(s) (Figure 8).
Referring to Figures 2 and 3, the device comprises a carrier 23 for carrying the container 1. According to a preferred embodiment of the invention, said carrier is formed by a front plate 25 and a slidable tray provided with a glass plate 24, onto which the container 1 can be placed. According to another embodiment, said carrier is formed by a front plate and a tray provided with a plate having an opening onto which plate the container can be placed, whereby the area of the opening is slightly smaller than the area of the container 1 to be placed. In this way, the container 1 to be placed fits exactly on the carrier, whereby the opening is provided for letting a light beam passing through it. Still according to another embodiment, said carrier comprises a fixed tray provided with a glass plate. The embodiments with the glass plate have the advantage, comparing to the embodiment with the plate having an opening, that the carrier is provided for carrying containers with a relatively wider range of dimensions.
The device further comprises a first light source 20 provided for emitting a first light beam (i.e. i1T, iic and in), see Figure 4, towards said container 1 and image forming means 21 for forming a first image of the content of the container 1. The image forming means 21 are for example formed by at least one sensor or a CCD camera. According to the invention, the first light source 20 and the image forming means 21 are situated at opposite sides of the carrier 23. The device further comprises data processing means such as a PC, provided for being connected to the image forming means and programmed for processing the data of the formed image.
Preferably the device comprises a second light source 22, situated at the same side of the carrier 23 than the image forming means 21 , in particular adjacent to said image forming means. The second light source 22 is provided for emitting a second light beam i2 (i.e. i2T, i2c and i2ι), see Figures 5-7, towards the container 1. The image forming means 21 are further provided for forming a second image of the content of the container 1 on the basis of the second light beam i2 at least partially reflected by said content. The second light source preferably emits a light beam which does not deform colours so that the formed second image clearly represents the colours of the content of the container.
Preferably, the device is enclosed in a closed box 26, so that the influence of external or ambient light is minimised. The operation of the device according to Figure 2 will now be described in detail.
Referring to Figure 4, the first light source 20 emits, in a first step, a first light beam h towards the container 1. As represented in Figure 4, three different sectors can be distinguished : sector T is a sector where a pharmaceutical tablet (indicated by 11-18 in Figures 1 and 8) is situated, sector C is a sector where the contaminated medium (indicated by 2 in Figure 1 ) is situated and sector I is a sector where an inhibition zone (indicated by 3-10 in Figure 1 ) is situated. A first light beam i1T emitted in a sector T will be reflected rιτ by the pharmaceutical tablet 13, since the pharmaceutical tablet is not transparent. In this sector, dark pixels will be formed on the image forming means. A first light beam i c emitted in sector C will essentially pass through the contaminated medium and be transmitted tic to the image forming means, since the contaminated medium is essentially transparent. Similarly, a first light beam in emitted in sector I will essentially pass through an inhibition zone and be transmitted tn to the image forming means, since the inhibition zone is essentially transparent. In sectors C and I, the image will consequently be clearly represented. Since an inhibition zone is more transparent than the contaminated medium, a small amount of the light beam iιc in sector C will be reflected r1C) whereas a negligible amount of the light beam i1t in sector I will be reflected. Consequently the formed image of the contaminated medium will be darker than the formed image of the inhibition zone and therefore the contour of the inhibition zone will clearly be formed. The amount of light transmitted towards the image forming means 21 is represented by the longer dots of dotted line tn compared to the dots of dotted line tιC.
In order to form a first image of the entire surface of the container 1 , the carrier slides from a first position, wherein a first extremity 27 of the container 1 is illuminated, towards a second position, wherein a second extremity 28 opposite to said first extremity of the container 1 is illuminated (Fig. 3).
The results of the formed first image is illustrated in Figure 1. Since the main portion of the first light beam passes through the areas of the contaminated medium and the inhibition zone(s), these areas are clearly represented. Since the inhibition zone(s) is (are) more transparent than the contaminated medium, the contour of the inhibition zone(s) can clearly be distinguished. Optionally the container could be provided with an identification label, such as for example a bar-code 19, in such a manner that when forming said first image, the identification label is also represented, so that formed images of different containers can easily be distinguished from each other.
Referring to Figures 5-7, the second light source 22 emits, in a second step, a second light beam i2 towards the container 1. A second light beam i2T emitted in a sector T (Figure 5) will be essentially reflected r2τ by the pharmaceutical tablet 17 towards the image forming means 21 , since the pharmaceutical tablet is not transparent. Consequently a clear image of the pharmaceutical tablet will be formed on the image forming means. A second light beam i2C emitted in sector C (Figure 6) will essentially pass through the contaminated medium and be transmitted t2C, since the contaminated medium is essentially transparent. Similarly, a second light beam i2, emitted in sector I (Figure 7) will essentially pass through an inhibition zone and be transmitted t2ι, since the inhibition zone is essentially transparent. In sectors C and I, dark pixels will consequently be formed on the image forming means. Such as in the first step, since an inhibition zone is more transparent than the contaminated medium, a small amount of the light beam i2c in sector C will be reflected r2C, whereas a negligible amount of the light beam i2ι in sector I will be reflected. Consequently the formed image of the inhibition zone will be darker than the formed image of the contaminated medium. In order to form a second image of the entire surface of the container, the carrier slides, such as in the first step, from a first position, wherein a first extremity 27 (Fig. 3) of the container 1 is illuminated, towards a second position, wherein a second extremity 28 (Fig. 3) opposite to said first extremity of the container 1 is illuminated.
The results of the formed second image is illustrated in Figure 8. Since the main portion of the second light beam reaching the pharmaceutical tablet(s) is reflected by these tablets, these tablets are clearly represented, whereas both the inhibition zones and the contaminated medium are less clearly represented compared to Figure 1. In this example, the pharmaceutical tablets can be distinguished from each other by their different marks such as for example identification letter(s) : APN (Ampicillin), AMX (Amoxycillin), TMN (Temocillin), CPS (Cephalospoπns of the first generation), CRX (Cefuroxime), CTX (Cefotaxime), CAZ (Ceftazidime) and TM (Tobramycim). According to another example, pharmaceutical tablets having different colours can be distinguished from each other by their different colours, provided the second image is coloured.
According to the Figures, the carrier is slidably mounted in said device and the light sources 20, 22 and the image forming means 21 are fixed on said device. According to another embodiment, said carrier is fixed and said light source(s) and said image forming means are slidably mounted in said device. If use is made of a CCD camera or (a) large sensor(s), neither the light source(s) and the camera, nor the carrier must be slidably mounted. The advantage of the slidable arrangement is that the distance between the first light source and the image forming means, on the one hand, and between the container and the image forming means, on the other hand, can be relatively small, so that the device according to the invention can be made relatively compact. According to a preferred embodiment, the device according to the invention is dimensioned in such a manner that it fits in a standard tower of a PC, so that it can be integrated in a PC.
The device comprises data processing means, for example in the PC, for determining, in a further step, the location of the pixels in the first image appertaining to the pharmaceutical tablet(s). These pixels can easily be detected since they are darker than the pixels pertaining to the contaminated medium and the inhibition zone(s). Corresponding pixels, having the same location, are determined in the second image and retrieved therefrom. Substitution means are provided for substituting said pixels appertaining to said pharmaceutical(s) tablet in said first image by said retrieved corresponding pixels in said second image. In this way a third image is formed whereby both the inhibition zone(s) and the pharmaceutical tablet(s) are accurately formed.
The device according to the invention enables to determine accurately the areas of the inhibition zone(s) and to provide in this way a more accurate analysis of the effect of the pharmaceutical tablet(s) in a contaminated medium.
From the description, it will be clear that the second light source is not absolutely necessary. Indeed, from the formed first image, the contour of the inhibition zone(s) can be determined. However, the pharmaceutical tablet(s) can not be distinguished from one another by their different colour of identification letter(s), but can be distinguished by their relative position to one another. In this case, a marking is preferably provided on the container, so that each pharmaceutical tablet can be distinguished from another one by its relative position with respect to the marking.
An essential feature of the invention is consequently that use is made of the described arrangement of the first light source and image forming means, known as transparency technique, for forming an image of a content of a container comprising at least one pharmaceutical tablet in a contaminated medium.

Claims

1. A device for forming an image of a content of a transparent container, in particular a Petri dish, which container is provided for carrying at least one pharmaceutical tablet in a contaminated medium, said device comprising a carrier for carrying said container, a first light source provided for emitting a first light beam towards said container and image forming means for forming a first image of said content, characterised in that said first light source and said image forming means are situated at opposite sides of said carrier, and that said carrier is provided for letting said first light beam through it in order to reach at least partially said image forming means.
2. Device according to claim 1 , characterised in that it further comprises a second light source, situated at the same side of said carrier than said image forming means, said second light source being provided for emitting a second light beam towards said container and said image forming means being further provided for forming a second image of said content on the basis of said second light beam at least partially reflected by said content.
3. Device according to claim 2, characterised in that it comprises means for determining pixels in said first, respectively said second image, appertaining to said pharmaceutical tablet(s) and substitution means for substituting said pixels in said first image appertaining to said pharmaceutical tablet by said pixels in said second image appertaining to said pharmaceutical tablet.
4. Device according to any one of the preceding claims, characterised in that it is enclosed in a closed box.
5. Device according to any one of the preceding claims, characterised in that said image forming means comprise at least one sensor.
6. Device according to any one of the claims 1 to 4, characterised in that said image forming means comprise a CCD camera.
PCT/BE1996/000080 1996-07-31 1996-07-31 Device for forming an image of a transparent container WO1998005794A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU66516/96A AU6651696A (en) 1996-07-31 1996-07-31 Device for forming an image of a transparent container
EP96926274A EP0925371A1 (en) 1996-07-31 1996-07-31 Device for forming an image of a transparent container
PCT/BE1996/000080 WO1998005794A1 (en) 1996-07-31 1996-07-31 Device for forming an image of a transparent container

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BE1996/000080 WO1998005794A1 (en) 1996-07-31 1996-07-31 Device for forming an image of a transparent container

Publications (1)

Publication Number Publication Date
WO1998005794A1 true WO1998005794A1 (en) 1998-02-12

Family

ID=3889502

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BE1996/000080 WO1998005794A1 (en) 1996-07-31 1996-07-31 Device for forming an image of a transparent container

Country Status (3)

Country Link
EP (1) EP0925371A1 (en)
AU (1) AU6651696A (en)
WO (1) WO1998005794A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786498A1 (en) * 1998-11-27 2000-06-02 Intelligence Artificielle Appl APPARATUS FOR AUTOMATICALLY READING AN ANTIBIOGRAM
EP2270514A1 (en) * 2009-07-03 2011-01-05 VidimSoft bvba Method for storing and tracing of manual blood typing analyses

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012036A1 (en) * 1994-10-17 1996-04-25 The Analytic Sciences Corporation Automated system and method for estimating antibiotic effectiveness from drug diffusion tests

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012036A1 (en) * 1994-10-17 1996-04-25 The Analytic Sciences Corporation Automated system and method for estimating antibiotic effectiveness from drug diffusion tests

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
A.J. HENK: "A new approach to overlay in monochrome television", JOURNAL OF THE SOCIETY OF MOTION PICTURE AND TELEVISION ENGINEERS, vol. 78, no. 10, October 1969 (1969-10-01), SCARSDALE US, pages 861 - 866, XP002028802 *
G. HEJBLUM ET AL: "Automated interpretation of disk diffusion antibiotic susceptibility tests with the radial profile analysis algorithm", JOURNAL OF CLINICAL MICROBIOLOGY, vol. 31, no. 9, September 1993 (1993-09-01), pages 2396 - 2401, XP000646843 *
L. CLONTZ: "Image analysis application to agar diffusion assays", AMERICAN CLINICAL LABORATORY, August 1992 (1992-08-01), pages 10 - 11, XP000646916 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786498A1 (en) * 1998-11-27 2000-06-02 Intelligence Artificielle Appl APPARATUS FOR AUTOMATICALLY READING AN ANTIBIOGRAM
WO2000032807A1 (en) * 1998-11-27 2000-06-08 Intelligence Artificielle Applications Sarl Apparatus for automatic reading of an antibiogram
EP2270514A1 (en) * 2009-07-03 2011-01-05 VidimSoft bvba Method for storing and tracing of manual blood typing analyses
WO2011000944A1 (en) * 2009-07-03 2011-01-06 Vidimsoft Bvba Method for storing and tracing of manual blood typing analyses

Also Published As

Publication number Publication date
EP0925371A1 (en) 1999-06-30
AU6651696A (en) 1998-02-25

Similar Documents

Publication Publication Date Title
JP3484196B2 (en) Method and apparatus for sorting material parts
US5965879A (en) Method and apparatus for ultra-high-sensitivity, incremental and absolute optical encoding
EP0078809B1 (en) Electro-optical mouse
US5403722A (en) Technique to count objects in a scanned image
US5463213A (en) Code mark reader
CA1329644C (en) Register measuring system and process
US7159780B2 (en) Method for reading a symbol having encoded information
JPH10332320A (en) Product scanning device and method
US5265169A (en) Method of discriminating particle aggregation pattern
DE69326096D1 (en) Method and device for reading data
US20040150217A1 (en) Identifying indicia and focusing target
US10803266B2 (en) Identification device and method for identifying identifiers on and/or features of laboratory objects and/or of samples located therein, and laboratory device having such an identification device
JPH11347969A (en) Method for marking at least one point on object
EP0925371A1 (en) Device for forming an image of a transparent container
AU726641B2 (en) Device for reading reliefs on a transparent container
JP3703365B2 (en) Imaging apparatus calibration system and method
US20210052468A1 (en) Systems and methods for vision based counting
EP0377454A3 (en) Image reading apparatus
US3735094A (en) Optical code reading system
EP3964133A1 (en) Method and system for encoding a surface position of an x-ray positioning device
JP2704145B2 (en) Label position detection device
JP2007172261A (en) Container with optical information, packaging material with optical information and reading method of optical information
EP0976093B1 (en) Form reader
US20050112587A1 (en) Analyzing biological probes
JP2549798B2 (en) Lighting imaging device

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AT AU AZ BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1996926274

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1998507400

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1996926274

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1996926274

Country of ref document: EP